The results showed that levels of GR and CD36 in liver tissues of model group were increased, and that HDP intervention downregulated GR and CD36 expression in liver tissues of NASH rats. This evidence concerns the gene NR3C1 and metabolic dysfunction-associated steatohepatitis.